| ICD Code | Description |
|---|---|
| C960 | Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis |
| C962 | Malignant mast cell tumor |
| C964 | Sarcoma of dendritic cells (accessory cells) |
| C965 | Multifocal and unisystemic Langerhans-cell histiocytosis |
| C966 | Unifocal Langerhans-cell histiocytosis |
| C96A | Histiocytic sarcoma |
| C96Z | Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue |
| C969 | Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C969 | Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified | 18.96 | |||||||||||||
| C966 | Unifocal Langerhans-cell histiocytosis | 21.21 | |||||||||||||
| C964 | Sarcoma of dendritic cells (accessory cells) | NA | |||||||||||||
| C96A | Histiocytic sarcoma | NA | |||||||||||||
| C962 | Malignant mast cell tumor | NA | |||||||||||||
| C960 | Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| ICD Code | ICD Description | Total National Projected Hospitalizations - Annualized (Present on Admission - All) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | Total Medicare Hospitalization after Exclusion | Avg. LOS | Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment Per Day | Payment Per Hospitalization | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C969 | Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified | 6.17 | 27.62 | ||||||||||||||||
| C966 | Unifocal Langerhans-cell histiocytosis | 6.48 | 29.02 | ||||||||||||||||
| C964 | Sarcoma of dendritic cells (accessory cells) | 6.49 | 39.29 | ||||||||||||||||
| C96A | Histiocytic sarcoma | 7.93 | 34.78 | ||||||||||||||||
| C962 | Malignant mast cell tumor | 7.86 | 28.28 | ||||||||||||||||
| C960 | Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis | 9.44 | 38.89 | ||||||||||||||||
| C965 | Multifocal and unisystemic Langerhans-cell histiocytosis | 5.97 | 32.35 | ||||||||||||||||
| C96Z | Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue | 9.63 | 47.83 |